Stock Analysis

Top Growth Companies With Insider Ownership November 2024

NSEI:NAZARA
Source: Shutterstock

In November 2024, global markets are experiencing a notable upswing, with U.S. indices reaching record highs following the Republican "red sweep" in the elections, which has fueled optimism around potential economic growth and tax reforms. This environment of heightened investor confidence underscores the importance of identifying growth companies where high insider ownership aligns interests and could potentially drive long-term value creation.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
Archean Chemical Industries (NSEI:ACI)22.9%45.4%
Kirloskar Pneumatic (BSE:505283)30.3%26.3%
Laopu Gold (SEHK:6181)36.4%33.9%
Medley (TSE:4480)34%30.4%
Pharma Mar (BME:PHM)11.8%56.4%
Findi (ASX:FND)34.8%64.8%
Credo Technology Group Holding (NasdaqGS:CRDO)13.9%95%
Alkami Technology (NasdaqGS:ALKT)11.2%98.6%
EHang Holdings (NasdaqGM:EH)32.8%81.4%
UTI (KOSDAQ:A179900)33.1%134.6%

Click here to see the full list of 1522 stocks from our Fast Growing Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Nazara Technologies (NSEI:NAZARA)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nazara Technologies Limited, along with its subsidiaries, operates a gaming and sports media platform across India, Africa, the Middle East, the Asia Pacific, the United States, and other international markets with a market cap of ₹67.51 billion.

Operations: The company's revenue is derived from three main segments: Gaming (₹3.90 billion), E-Sports (₹6.46 billion), and AD Tech Business (₹1.02 billion).

Insider Ownership: 22.1%

Nazara Technologies is experiencing significant earnings growth, forecasted at 24.9% annually, outpacing the Indian market. Despite this, its return on equity is projected to be low in three years. Recent board changes and a substantial private placement raising INR 9 billion indicate strategic shifts and potential dilution concerns. The company's revenue growth of 17.9% surpasses the market average but remains below high-growth benchmarks, highlighting both opportunities and challenges for investors focused on insider ownership dynamics.

NSEI:NAZARA Earnings and Revenue Growth as at Nov 2024
NSEI:NAZARA Earnings and Revenue Growth as at Nov 2024

Vimian Group (OM:VIMIAN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Vimian Group AB (publ) operates in the global animal health industry and has a market capitalization of SEK22.03 billion.

Operations: The company generates revenue from four main segments: Medtech (€112.75 million), Diagnostics (€20.32 million), Specialty Pharma (€163.45 million), and Veterinary Services (€56.11 million).

Insider Ownership: 11.1%

Vimian Group faces mixed financial dynamics, with earnings forecasted to grow significantly at 94.1% annually, outpacing the Swedish market. However, recent results show a net loss of EUR 2.13 million in Q3 2024 despite increased sales of EUR 87.65 million. Insider transactions have been minimal recently, and shares were diluted over the past year. The stock trades below its estimated fair value by 20.1%, presenting potential value for investors considering insider ownership trends amidst these challenges.

OM:VIMIAN Earnings and Revenue Growth as at Nov 2024
OM:VIMIAN Earnings and Revenue Growth as at Nov 2024

Ficont Industry (Beijing) (SHSE:605305)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Ficont Industry (Beijing) Co., Ltd. manufactures and supplies wind turbine tower internals and safety systems for wind turbine manufacturers in China and internationally, with a market cap of CN¥6.12 billion.

Operations: The company's revenue is derived from its Construction Machinery & Equipment segment, totaling CN¥1.34 billion.

Insider Ownership: 27.9%

Ficont Industry (Beijing) shows promising growth with recent earnings rising to CNY 238.29 million for the first nine months of 2024, doubling from a year ago. Revenue increased significantly to CNY 934.08 million, reflecting strong business performance. The stock trades at a substantial discount to its estimated fair value and is expected to grow revenue by over 24% annually, outpacing the Chinese market's growth rate, although its earnings growth lags slightly behind market expectations.

SHSE:605305 Earnings and Revenue Growth as at Nov 2024
SHSE:605305 Earnings and Revenue Growth as at Nov 2024

Next Steps

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're here to simplify it.

Discover if Nazara Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com